Early Intervention With Therapeutic Exercise in Plantar Fasciopathy
Launched by UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE · Apr 26, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special exercise program for people with plantar fasciitis, a common foot condition that causes pain in the heel. The goal is to see if starting this exercise program early can help strengthen the muscles in the hip and foot, potentially reducing pain and improving daily activities.
To join the study, participants should be experiencing pain in the bottom part of their heel for at least three months, especially when they first get up in the morning or after standing for a long time. However, people who are pregnant, have had certain injections in their foot recently, or have other serious medical conditions affecting their movement will not be eligible to participate. Those who join can expect to follow a guided exercise routine designed to help alleviate their symptoms and improve their overall foot health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with referred pain in the medial plantar area of the heel, accentuated with initial steps after a period of inactivity but also worsening after prolonged body weight bearing, of at least 3 months evolution prior to inclusion in the study.
- • Reproduction of the pain referred by the patient with palpation at the proximal insertion of the plantar fascia.
- Exclusion Criteria:
- • Pregnancy.
- • Injection of corticoids in the area in the 6 months prior to recruitment.
- • Previous illnesses that may alter gait (central or peripheral neurological pathology, degenerative and inflammatory arthropathies, systemic illnesses).
- • Existence of concomitant foot pathology (metatarsalgia, stress fractures, neuropathies due to entrapment, tendinitis, history of foot/ankle surgery, etc.).
- • People who do not have the capacity to understand and follow an exercise programme.
About Universidad Miguel Hernandez De Elche
Universidad Miguel Hernández de Elche is a prominent academic institution in Spain, renowned for its commitment to advancing medical research and education. The university actively engages in clinical trials aimed at enhancing patient care and addressing critical health challenges. With a multidisciplinary approach, it leverages its expertise in biomedical sciences, clinical medicine, and public health to drive innovative research initiatives. Through collaboration with healthcare professionals and institutions, Universidad Miguel Hernández de Elche promotes evidence-based practices and contributes significantly to the development of new therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Elche, Alicante, Spain
Patients applied
Trial Officials
Javier Marco, PhD
Study Chair
Universidad Miguel Hernandez de Elche
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported